Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD

Chronic graft-versus-host disease (cGvHD) remains a prominent barrier to allogeneic hematopoietic stem cell transplantion as the leading cause of nonrelapse mortality and significant morbidity. Tremendous progress has been achieved in both the understanding of pathophysiology and the development of...

Descripción completa

Detalles Bibliográficos
Autores principales: Buxbaum, Nataliya P., Socié, Gerard, Hill, Geoffrey R., MacDonald, Kelli P. A., Tkachev, Victor, Teshima, Takanori, Lee, Stephanie J., Ritz, Jerome, Sarantopoulos, Stefanie, Luznik, Leo, Zeng, Defu, Paczesny, Sophie, Martin, Paul J., Pavletic, Steven Z., Schultz, Kirk R., Blazar, Bruce R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463203/
https://www.ncbi.nlm.nih.gov/pubmed/36322878
http://dx.doi.org/10.1182/bloodadvances.2022007611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463203/
https://www.ncbi.nlm.nih.gov/pubmed/36322878
http://dx.doi.org/10.1182/bloodadvances.2022007611

Ejemplares similares